Preventive effect of phosphodiesterase 5 inhibitor tadalafil on experimental post-pyelonephritic renal injury in rats.

[1]  Anindita Das,et al.  Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice. , 2013, Free radical biology & medicine.

[2]  L. Madsen,et al.  ERRγ enhances UCP1 expression and fatty acid oxidation in brown adipocytes , 2013, Obesity.

[3]  G. Nikiforidis,et al.  PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection? , 2013, World Journal of Urology.

[4]  T. Nevéus.  Can postpyelonephritic renal scarring be prevented? , 2013, Pediatric Nephrology.

[5]  M. Kiray,et al.  Protective effects of bilirubin in an experimental rat model of pyelonephritis. , 2012, Urology.

[6]  P. Ortiz,et al.  β-Adrenergic receptor stimulation increases surface NKCC2 expression in rat thick ascending limbs in a process inhibited by phosphodiesterase 4. , 2012, American journal of physiology. Renal physiology.

[7]  R. von Bernhardi,et al.  Transforming growth factor‐β stimulates β amyloid uptake by microglia through Smad3‐dependent mechanisms , 2012, Journal of neuroscience research.

[8]  G. Chrysant,et al.  The Pleiotropic Effects of Phosphodiesterase 5 Inhibitors on Function and Safety in Patients With Cardiovascular Disease and Hypertension , 2012, Journal of clinical hypertension.

[9]  I. Petrova,et al.  [Comparative effectiveness of fluoroquinolones and beta-lactams in the complex therapy of patients with chronic pyelonephritis]. , 2012, Urologiia.

[10]  R. Medhamurthy,et al.  Involvement of Src family of kinases and cAMP phosphodiesterase in the luteinizing hormone/chorionic gonadotropin receptor-mediated signaling in the corpus luteum of monkey , 2012, Reproductive Biology and Endocrinology.

[11]  Saisudha Koka,et al.  Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts , 2012, Basic Research in Cardiology.

[12]  T. Çaycı,et al.  Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis , 2011, Scandinavian journal of clinical and laboratory investigation.

[13]  C. Page,et al.  Phosphodiesterase inhibitors in the treatment of inflammatory diseases. , 2011, Handbook of experimental pharmacology.

[14]  M. Eisenhut,et al.  Ion channels in inflammation , 2011, Pflügers Archiv - European Journal of Physiology.

[15]  J. Corbin,et al.  cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action , 2010, Pharmacological Reviews.

[16]  I. Ure,et al.  Renal tissue damage after experimental pyelonephritis: role of antioxidants and selective cyclooxygenase-2 inhibitors. , 2010, Urology.

[17]  C. Chai,et al.  The xanthine derivative KMUP‐1 inhibits models of pulmonary artery hypertension via increased NO and cGMP‐dependent inhibition of RhoA/Rho kinase , 2010, British journal of pharmacology.

[18]  R. Mittal,et al.  Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. , 2008, Microbial pathogenesis.

[19]  S. Çelik,et al.  Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats. , 2008, Urology.

[20]  Rashmi R Sharma.  Novel phosphodiesterase-5 inhibitors: current indications and future directions. , 2007, Indian journal of medical sciences.

[21]  L. Kaptanoğlu,et al.  Effect of a Selective Cyclooxygenase-2 Inhibitor on Renal Scarring , 2006, European Surgical Research.

[22]  C. Karahan,et al.  Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis. , 2006, Urology.

[23]  C. Page,et al.  Phosphodiesterase inhibitors , 2006, British journal of pharmacology.

[24]  Golod Ea,et al.  The role of oxygen radicals in metabolic disorders in the kidneys of patients with acute and chronic pyelonephritis , 2006 .

[25]  E. Golod,et al.  [The role of oxygen radicals in metabolic disorders in the kidneys of patients with acute and chronic pyelonephritis]. , 2006, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[26]  Wenjie Bao,et al.  Carbon monoxide prevents apoptosis induced by uropathogenic Escherichia coli toxins , 2006, Pediatric Nephrology.

[27]  E. Barrett-Connor,et al.  Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). , 2005, The American journal of cardiology.

[28]  Golod Ea,et al.  An increase in the active oxygen forms as a cause of metabolic disorders in renal tubular cells in patients with acute and chronic pyelonephritis , 2003 .

[29]  E. Serlachius,et al.  Pyelonephritis provokes growth retardation and apoptosis in infant rat renal cortex. , 1997, Kidney international.

[30]  N. Cortas,et al.  Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. , 1990, Clinical chemistry.

[31]  Y. Sun,et al.  A simple method for clinical assay of superoxide dismutase. , 1988, Clinical chemistry.

[32]  T. Yoshioka,et al.  Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. , 1979, American journal of obstetrics and gynecology.

[33]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[34]  D. Kaye.  The effect of water diuresis on spread of bacteria through the urinary tract. , 1971, The Journal of infectious diseases.